Connexin hemichannel inhibition improves skin pathology in Clouston syndrome mice

[1]  F. Mammano,et al.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice , 2020, EBioMedicine.

[2]  D. Laird,et al.  Therapeutic strategies targeting connexins , 2018, Nature Reviews Drug Discovery.

[3]  F. Mammano,et al.  Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders , 2017, Front. Mol. Neurosci..

[4]  K. Willecke,et al.  From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome. , 2016, The Journal of investigative dermatology.

[5]  C. Sellitto,et al.  Connexin channels in congenital skin disorders. , 2016, Seminars in cell & developmental biology.

[6]  K. Willecke,et al.  The Clouston syndrome mutation connexin30 A88V leads to hyperproliferation of sebaceous glands and hearing impairments in mice , 2014, FEBS letters.

[7]  V. Verselis,et al.  Connexin channel modulators and their mechanisms of action , 2013, Neuropharmacology.

[8]  A. Charollais,et al.  Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. , 2004, Human molecular genetics.

[9]  R. Bruzzone,et al.  Connections with connexins: the molecular basis of direct intercellular signaling. , 1996, European journal of biochemistry.

[10]  M. Bortolozzi,et al.  Cx32 hemichannel opening by cytosolic Ca2+ is inhibited by the R220X mutation that causes Charcot-Marie-Tooth disease , 2018, Human molecular genetics.